Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMG4UJ6)

Drug Name

EVK-001 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Diabetic gastroparesis	DA41.00	Phase 3	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Dopamine receptor (DR)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Neupro	DMHEAB1	Restless legs syndrome	7A80	Phase 4	[3]
ABBV-951	DMMWO7V	Parkinson disease	8A00.0	Phase 3	[4]
ONC201	DMM5SCF	Endometrial cancer	2C76	Phase 2	[5]
L-piperazino-3-phenyl-indane derivative 1	DM1STAD	N. A.	N. A.	Patented	[6]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Clinical pipeline report, company report or official report of Evoke Pharma.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	Rotigotine Transdermal Patch: A Review in Parkinson's Disease. CNS Drugs. 2019 Jul;33(7):707-718.
4	Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease. Ann Neurol. 2021 Jul;90(1):52-61.
5	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
6	Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014).Expert Opin Ther Pat. 2016;26(1):89-106.